Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Market movers: Abercrombie, Bath & Body Works, CrowdStrike, GitHub, Wix...

GitLab (NASDAQ:GTLB) reported fourth quarter fiscal 2026 earnings that exceeded Wall Street expectations, but the company’s shares dropped about 7% in early trading on its cautious guidance for the upcoming year.

For the quarter ended January 31, 2026, GitLab posted adjusted earnings per share of $0.30, surpassing the consensus of $0.23.

Read more

Wix shares jumped about 14% on Wednesday after the website-building platform reported fourth-quarter earnings that topped expectations and outlined continued profitability gains, despite a slight revenue miss.

For the fourth quarter, Wix reported earnings of $1.81 per share, beating the consensus estimate of $1.36 per share.

Read more

Shares of Abercrombie & Fitch (NYSE:ANF) fell 6.4% Wednesday morning after the company delivered solid fourth-quarter results but issued a cautious outlook for fiscal 2026, highlighting tariff-related margin pressure and moderating growth.

The retailer posted record fourth-quarter net sales of $1.67 billion, up 5% year-over-year, marking its thirteenth consecutive quarter of growth. Comparable sales rose 1%.

Read more

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) stock added almost 9% after it was announced that the drugmaker has agreed to pay up to $2.25 billion to settle a global patent infringement lawsuit brought by Arbutus Biopharma and Genevant Sciences over the use of lipid nanoparticle (LNP) delivery technology in its COVID-19 and RSV vaccines.

The settlement resolves all US and international enforcement actions related to Moderna’s use of Arbutus’ and Genevant’s LNP technology in Spikevax, its COVID-19 vaccine, and mRESVIA, its RSV vaccine.

Read more

Ross Stores Inc (NASDAQ:ROST) shares jumped about 6% in early trade on Wednesday after the off-price retailer reported stronger-than-expected fourth-quarter results and issued fiscal 2026 guidance calling for further sales and earnings growth.

For the quarter ended January 31, 2026, total sales increased 12% to $6.6 billion, ahead of Wall Street expectations of approximately $6.37 billion.

Read more

Bath & Body Works Inc (NYSE:BBWI) shares rose more than 6% in premarket trading after the retailer reported fourth quarter earnings and revenue that topped Wall Street’s expectations.

The company reported adjusted earnings per diluted share of $2.05 for the quarter ended January 31, 2026, exceeding the $1.75 consensus estimate. Revenue totaled $2.7 billion, ahead of expectations for $2.6 billion.

Read more

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK